Recent Analyst Forecasts and Stock Ratings
NGM Biopharmaceuticals, Inc. FAQ's
NGM Biopharmaceuticals, Inc. has been rated by research analysts at Raymond James, Goldman Sachs in the past 90 days.
NGM Biopharmaceuticals, Inc. has been rated by research analysts at Raymond James, Goldman Sachs in the past 90 days.